Artemis Alpha | ATS - Capitale Ordinario



Capitale Ordinario Cambiamento Data
3i Infrastructure GBP 922.35M 0 2025-12
AstraZeneca USD 1.55B 206K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12